Click here for a live version of this chart.
The Biotech ETF has had a devil of a time getting above 92 this year. Right now it is trying again. The low volume numbers don't bode well but remember that ETF volume data can be tricky to interpret. A close above 92 would do wonders for this chart. Time will tell - as always.
In this week’s show, Mary Ellen highlights the stocks and groups showing the most promise following the Fed’s rate cut. She spotlights leadership in technology, software, and semiconductors, while also pointing out opportunities in small-cap AI names, robotics, crypto, and biotechs. Mary Ellen shares how industrials, uranium, and... READ MORE
Another week, another record-setting close in the major indexes. With the S&P 500 ($SPX) up over 13% so far this year, investors are seeing gains far beyond what CDs or money markets can deliver. The stock market may seem to be a complex and risky beast, but here’... READ MORE
Before We Dive In… How do you turn a quick morning scan into a market edge? With SCTR Reports. In this article, we’ll cover how SCTRs rank stocks, how to scan them fast, and how to spot leaders, laggards, and turnarounds in minutes. This is your quick-start guide to... READ MORE
While technology stocks have stalled out over the last six weeks, other growth sectors have stepped into a leadership role. Here are the charts Dave uses regularly to track leadership themes, and identify when new sectors are improving in relative strength terms.... READ MORE
Late September is historically tough for stocks. Mike explores why the S&P 500, Materials (XLB), and low-volatility put options could define the weeks ahead.... READ MORE
Learn how to trade credit spreads for consistent income. Tony Zhang shows simple setups, risk manage, and automation with the OptionsPlay Strategy Center from StockCharts.com... READ MORE